Cathay Biotech Inc. (SHA:688065)

China flag China · Delayed Price · Currency is CNY
48.13
+0.61 (1.28%)
Jun 25, 2025, 2:45 PM CST
2.86%
Market Cap 34.75B
Revenue (ttm) 3.05B
Net Income (ttm) 520.65M
Shares Out 720.66M
EPS (ttm) 0.89
PE Ratio 54.16
Forward PE 67.92
Dividend 0.40 (0.84%)
Ex-Dividend Date Jul 24, 2024
Volume 1,915,329
Average Volume 1,943,990
Open 47.50
Previous Close 47.52
Day's Range 47.30 - 48.29
52-Week Range 32.48 - 56.98
Beta 0.62
RSI 47.21
Earnings Date Aug 14, 2025

About Cathay Biotech

Cathay Biotech Inc., a bio-manufacturing technology company, researches, develops, produces, and sells bio-based materials in China and internationally. It offers biological long-chain diacids comprising sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine. The products are used in various applications, including textiles, pharmaceuticals, perfumes, automobiles, electronic appliances, consumer goods, and other industries. It provides its products under the TERRYL and ECOPENT brands. Cathay Biotech In... [Read more]

Industry Chemicals
Sector Materials
Founded 2000
Employees 1,735
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688065
Full Company Profile

Financial Performance

In 2024, Cathay Biotech's revenue was 2.96 billion, an increase of 39.91% compared to the previous year's 2.11 billion. Earnings were 488.96 million, an increase of 33.41%.

Financial Statements

News

There is no news available yet.